Related references
Note: Only part of the references are listed.Personalization of Logical Models With Multi-Omics Data Allows Clinical Stratification of Patients
Jonas Beal et al.
FRONTIERS IN PHYSIOLOGY (2019)
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
Raphael Brandt et al.
NATURE COMMUNICATIONS (2019)
Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway Model
Fabian Froehlich et al.
CELL SYSTEMS (2018)
Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials
Anne Marie Barrette et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Cell-Specific Computational Modeling of the PIM Pathway in Acute Myeloid Leukemia
Dana Silverbush et al.
CANCER RESEARCH (2017)
Drug Resistance Mechanisms in Colorectal Cancer Dissected with Cell Type-Specific Dynamic Logic Models
Federica Eduati et al.
CANCER RESEARCH (2017)
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
Dirk Fey et al.
SCIENCE SIGNALING (2015)
Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells
Anil Korkut et al.
ELIFE (2015)
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
Dirk Fey et al.
SCIENCE SIGNALING (2015)
Network quantification of EGFR signaling unveils potential for targeted combination therapy
Bertram Klinger et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Share Paper
